Starsource Multitrade (506365) Q4 09/10 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 09/10 earnings summary
21 Oct, 2026Executive summary
Manufacturing remained suspended throughout FY10; operations centered on share trading and other investments, while management continued exploring viable diversification opportunities.
Miscellaneous income fell and the year ended in a loss; auditors highlighted going-concern, investment-valuation and related-party loan concerns.
Financial highlights
Income was Rs 101,936 in FY10 vs Rs 412,823 in FY09, entirely from miscellaneous income; expenses rose to Rs 534,682 from Rs 316,092.
The profit-and-loss account reports a FY10 loss of Rs 511,936 vs Rs 84,829 in FY09; the Directors’ Report and MD&A state a loss before and after tax of Rs 5.67 lakh vs prior-year profit of Rs 0.85 lakh.
The EPS note lists a PAT loss of Rs 566,915 for FY10, while showing basic and diluted EPS of Rs 0.378; FY09 figures are loss Rs 84,829 and EPS Rs 0.057.
Outlook and guidance
The Board was exploring new business avenues and seeking a viable activity compatible with existing constraints; diversification had made no significant progress.
Latest events from Starsource Multitrade
- Tax write-back lifted net profit as factory operations restarted and Fine Chemicals trials advanced.506365
Q4 96/97 - A continuing factory lockout and Rs. 83,23,334 pre-tax loss defined the year.506365
Q4 97/98 - Continued lockout, Rs.4.488m net loss, and major unprovided liabilities and investment impairment.506365
Q4 98/99 - Lockout and a widening Rs.4.38m loss drove plans to explore disposal or leasing.506365
Q4 04/05 - Lockout halted operations; FY2002-03 net loss was Rs.863,221 as leasing talks continued.506365
Q4 02/03 - Manufacturing ceased after asset sales; diversification and material financial risks remain.506365
Q4 06/07 - Manufacturing stayed halted; FY08 PAT fell to Rs 0.08 lakh as diversification remained uncertain.506365
Q4 07/08 - A modest return to profit amid suspended operations, material audit concerns, and suspended share trading.506365
Q4 10/11 - Investment-sale income drove FY12 profit as manufacturing remained suspended.506365
Q4 11/12